Jaguar Health, Inc. (JAGX)

NASDAQ: JAGX · IEX Real-Time Price · USD
0.320
+0.017 (5.72%)
At close: Jun 24, 2022 4:00 PM
0.313
-0.007 (-2.188%)
Pre-market: Jun 27, 2022 8:01 AM EDT

Income Statement (Annual)

Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Year 20212020201920182017201620152014
Revenue
4.349.395.784.424.360.140.260
Revenue Growth (YoY)
-53.81%62.51%30.77%1.26%2981.61%-45.23%--
Cost of Revenue
2.333.283.822.770.880.050.120
Gross Profit
26.111.961.653.480.090.130
Selling, General & Admin
262120.4422.1114.336.476.14.1
Research & Development
15.086.415.825.154.277.216.484.22
Other Operating Expenses
1.635.344.655.2119.13000
Operating Expenses
42.7132.7530.9132.4737.7313.6812.588.32
Operating Income
-40.71-26.65-28.95-30.82-34.25-13.59-12.45-8.32
Interest Expense / Income
8.422.795.732.631.210.993.320.35
Other Expense / Income
3.474.373.85-1.31-0.310.160.53-0.05
Pretax Income
-52.6-33.81-38.53-32.15-35.15-14.73-16.29-8.61
Income Tax
000.010-13.18000
Net Income
-52.6-33.81-38.54-32.15-21.97-14.73-16.29-8.61
Preferred Dividends
04.846.190000.350.65
Net Income Common
-52.6-38.65-44.73-32.15-21.97-14.73-16.64-9.26
Shares Outstanding (Basic)
4513200000
Shares Outstanding (Diluted)
4513200000
Shares Change
247.12%678.25%2267.50%406.99%296.58%78.03%115.56%-
EPS (Basic)
-1.18-3.00-27.03-459.81-1.00-4.00-8.00-10.00
EPS (Diluted)
-1.18-3.00-27.03-459.81-1.00-4.00-8.00-10.00
Free Cash Flow Per Share
-0.78-1.19-12.36-325.24-712.52-4.00-7.00-5.00
Gross Margin
46.18%65.05%33.92%37.37%79.81%63.28%52.22%-
Operating Margin
-939.05%-283.93%-501.26%-697.98%-785.27%-9599.84%-4816.67%-
Profit Margin
-1213.26%-411.81%-774.48%-727.92%-503.73%-10410.87%-6439.30%-
Free Cash Flow Margin
-806.83%-162.87%-354.23%-514.87%-225.28%-10258.35%-5541.65%-
Effective Tax Rate
0.00%0.00%-0.03%0.00%37.50%0.00%0.00%0.00%
EBITDA
-42.37-28.74-30.87-28.2-33.36-13.7-12.97-8.26
EBITDA Margin
-977.30%-306.20%-534.54%-638.53%-764.83%-9680.93%-5019.37%-
Depreciation & Amortization
1.812.281.931.320.580.050.010
EBIT
-44.18-31.02-32.8-29.52-33.94-13.75-12.97-8.26
EBIT Margin
-1019.12%-330.50%-567.93%-668.40%-778.23%-9714.49%-5021.37%-
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).